• 3/3/2006
  • Bethesda, MD
  • Naghma Khan et al.
  • Cancer Research 66, 2500-2505, March 1, 2006

Cell signaling pathways, responsible for maintaining a balance between cell proliferation and death, have emerged as rational targets for the management of cancer.

Emerging data amassed from various laboratories around the world suggests that green tea, particularly its major polyphenolic constituent (–)-epigallocatechin-3-gallate (EGCG), possesses remarkable cancer chemopreventive and therapeutic potential against various cancer sites in animal tumor bioassay systems and in some human epidemiologic studies.

EGCG has been shown to modulate multiple signal transduction pathways in a fashion that controls the unwanted proliferation of cells, thereby imparting strong cancer chemopreventive as well as therapeutic effects. This review discusses the modulations of important signaling events by EGCG and their implications in cancer management.(Cancer Res 2006;66(5):2500–5)

Authors:
Naghma Khan, Farrukh Afaq, Mohammad Saleem, Nihal Ahmad and Hasan Mukhtar

Authors’ affiliation:
Department of Dermatology, University of Wisconsin-Madison, Madison, Wisconsin